Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for medicines containing the active ingredient cefuroxime in parenteral form (ATC code: J01DC02) that are approved for prescription and dispensing within the scope of outpatient care needs in Lower Saxony.
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Cefuroxim in parenteraler Darreichungsform (ATC-Code: J01DC02).
Germany · Hannover · how to bid here →
Your path to submission
- Deadline: 27 August at 00:00 — 711 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- 27% of this buyer's awards went to companies that had already won here before (12 awards since 2022, spread over 9 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 12 awards since 2022
- The median procedure drew just one bid (10 procedures with a bid count); 90% ended with a single bidder. Sector: median 2 bids.n = 10
- 8% of awards went to companies from abroad (12 awards with a known winner country). Sector average: 1%.n = 12
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 13/09/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 257 contracts went to foreign companies over the last 3 years (of 21,997 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 2 (from 21,252 awards).
What the buyer is looking for
The summary in English is being prepared. The official description below is in the original language (DE).
Show original description (DE)
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Cefuroxim in parenteraler Darreichungsform (ATC-Code: J01DC02) innerhalb des Zeitraumes vom 01.11.2026 bis zum 31.10.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“). In Niedersachsen haben Apotheken auch im Sprechstundenbedarf ab dem 01.07.2026 vorrangig Fertigarzneimittel abzugeben, für die ein Rabattvertrag nach § 130a Abs. 8 SGB V besteht.
What you must prove — eligibility criteria
Gemäß § 130a Abs. 8 Satz 1 SGB V können Rabattverträge nur mit pharmazeutischen Unternehmern i. S. d. § 4 Abs. 18 AMG (bzw. einer Vertragsgemeinschaft aus pharmazeutischen Unternehmern) abgeschlossen werden, wobei sich die Eigenschaft der Vertragspartner als p… ▸▾
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Horn GmbH · Stutensee | 3 | 2025 |
| DIGOTEX GmbH · Niederfischbach | 2 | 2026 |
| Binect GmbH · Weiterstadt | 1 | 2026 |
| COMRAMO AG · Hannover | 1 | 2026 |
| Klinikverbund Landkreis Diepholz gGmbH | 1 | 2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.